BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 37340564)

  • 21. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
    Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
    Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
    Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
    Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?
    Pilkington SM; Watson REB
    Br J Dermatol; 2021 Dec; 185(6):1090-1091. PubMed ID: 34748213
    [No Abstract]   [Full Text] [Related]  

  • 24. An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers.
    Mohta A; Mohta A; Nai RS; Arora A; Jain SK; Mohta A; Mehta RD; Ghiya BC; Prasad V; Khokhar R; Toteja R; Bha Rgava G
    Indian Dermatol Online J; 2021; 12(5):687-695. PubMed ID: 34667754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A window of opportunity for intensifying testing and tracing efforts to prevent new COVID-19 outbreaks due to more transmissible variants.
    Wu J; Scarabel F; McCarthy Z; Xiao Y; Ogden NH
    Can Commun Dis Rep; 2021 Jul; 47(7-8):329-338. PubMed ID: 34667443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Skin Manifestations in Skin of Colour.
    Akuffo-Addo E; Nicholas MN; Joseph M
    J Cutan Med Surg; 2022; 26(2):189-197. PubMed ID: 34663122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
    Gambichler T; Boms S; Susok L; Dickel H; Finis C; Abu Rached N; Barras M; Stücker M; Kasakovski D
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):172-180. PubMed ID: 34661927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study.
    Poizeau F; Oger E; Barbarot S; Le Corre Y; Samimi M; Brenaut E; Aubert H; Chambrelan E; Droitcourt C; Gissot V; Heslan C; Laurent C; Martin L; Misery L; Tattevin P; Toubel A; Thibault V; Dupuy A
    Clin Microbiol Infect; 2022 Feb; 28(2):285-291. PubMed ID: 34619397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio.
    Arkin LM; Moon JJ; Tran JM; Asgari S; O'Farrelly C; Casanova JL; Cowen EW; Mays JW; Singh AM; Drolet BA;
    J Invest Dermatol; 2021 Dec; 141(12):2791-2796. PubMed ID: 34561087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.
    Sánchez-García V; Hernández-Quiles R; de-Miguel-Balsa E; Docampo-Simón A; Belinchón-Romero I; Ramos-Rincón JM
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):24-38. PubMed ID: 34545625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term Outcome of Chilblains Associated with SARS-CoV-2.
    Poizeau F; Barbarot S; Le Corre Y; Brenaut E; Samimi M; Aubert H; Toubel A; Dupuy A
    Acta Derm Venereol; 2021 Dec; 101(12):adv00614. PubMed ID: 34515805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "COVID toes": A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings.
    Rocha KO; Zanuncio VV; Freitas BAC; Lima LM
    Pediatr Dermatol; 2021 Sep; 38(5):1143-1149. PubMed ID: 34515379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
    Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
    J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic.
    Cassius C; Merandet M; Frumholtz L; Bergerat D; Samri A; Grolleau C; Grzelak L; Schwartz O; Yatim N; Moghadam P; Jaume L; Bagot M; Legoff J; Delaugerre C; Bouaziz JD; Le Buanec H;
    Br J Dermatol; 2021 Dec; 185(6):1242-1244. PubMed ID: 34258762
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic.
    McCleskey PE; Zimmerman B; Lieberman A; Liu L; Chen C; Gorouhi F; Jacobson CC; Lee DS; Sriram A; Thornton A; Herz AM; Mirmirani P; Herrinton LJ
    JAMA Dermatol; 2021 Aug; 157(8):947-953. PubMed ID: 34160569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse of chilblain-like lesions during the second wave of the COVID-19 pandemic: a cohort follow-up.
    Hubiche T; Le Duff F; Fontas E; Rapp J; Chiaverini C; Passeron T
    Br J Dermatol; 2021 Oct; 185(4):858-859. PubMed ID: 34128539
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency of relapse and persistent cutaneous symptoms after a first episode of chilblain-like lesion during the COVID-19 pandemic.
    Moghadam P; Frumholtz L; Jaume L; De Masson A; Jachiet M; Begon E; Sulimovic L; Petit A; Bachelez H; Bagot M; Bouaziz JD; Cassius C;
    J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e566-e568. PubMed ID: 34036642
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous manifestations associated with COVID-19 in children: A systematic review.
    Shah S; Akhade K; Ganguly S; Nanda R; Mohapatra E; Goel AK
    J Family Med Prim Care; 2021 Jan; 10(1):93-101. PubMed ID: 34017709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
    Kashetsky N; Mukovozov IM; Bergman J
    J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.
    Gisondi P; Di Leo S; Bellinato F; Cazzaniga S; Piaserico S; Naldi L
    Dermatol Ther (Heidelb); 2021 Jun; 11(3):695-705. PubMed ID: 33811315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.